pediatric patients - Diabetes Research Connection

Diabetes Research News
July 23, 2020

Taking Steps to Prevent Diabetic Ketoacidosis in Pediatric Patients with Type 1 Diabetes

There are many complications that can occur with type 1 diabetes, but one of the most serious is diabetic ketoacidosis (DKA). When the body does not produce (or have) enough insulin to help convert sugar to energy, it begins breaking down fat and using that as fuel instead. However, this releases acid known as ketones into the bloodstream, in turn leading to DKA when levels become too high.

A recent study found that DKA among newly diagnosed pediatric patients with type 1 diabetes is alarmingly high among patients around the world. During an 11-year study spanning from 2006 to 2016, researchers found that out of 59,000 children who had been diagnosed with T1D, 29.9% presented with DKA at diagnosis. The study examined data from children in Austria, the Czech Republic, Germany, Italy, Luxembourg, Norway, Slovenia, Sweden, Wales, Australia, New Zealand, and the United States.

Of these countries, prevalence rates in Luxembourg and Italy were found to be the highest at 43.8% and 41.2%, respectively, while Sweden and Denmark had the lowest rates at 19.5% and 20.8%, respectively. DKA at diabetes diagnosed increased over the 11-year study in the United States, Australia, and Germany. Overall, DKA tended to impact a higher proportion of females than males, except in Wales.

In order to help reduce risk of DKA at diagnosis, the researchers encourage improved screenings beginning with young children. For example, Bavaria, Germany tests for islet autoantibodies as part of a public health screening for children between the ages of 2 and 5. Studies showed that their prevalence of DKA at diagnosis came in at less than 5%. Increased screenings and education may be beneficial in raising awareness and catching potential problems early on before DKA develops.

Though not involved with this study, the Diabetes Research Connection (DRC) is committed to improving understanding, prevention, and treatment of type 1 diabetes by providing critical funding for novel, peer-reviewed research studies by early-career scientists. Find out how to support these efforts and learn more about current projects by visiting https://diabetesresearchconnection.org.

Learn More +

Diabetes Research News
June 4, 2020

Using Telehealth to Enhance Pediatric Type 1 Diabetes Management

Telehealth has come a long way in improving access to care. It has become even easier for patients to connect with healthcare providers without going to their office. Using available technology, a recent study out of the University of California, Davis (UC Davis) examined whether management of type 1 diabetes (T1D) in pediatric patients could be improved through telehealth.

Fifty-seven patients under the age of 18 participated in the study where they were connected with a member of the research team every four, six, or eight weeks via video conference for at least one year. This was in addition to quarterly clinic visits. All of the patients had suboptimal glycemic control before the study began, and most lived at least 30 miles away from the hospital.

The program was led by Stephanie Crossen, a pediatric endocrinologist at UC Davis Health. Prior to each video call, patients sent data from their diabetes devices for Crossen and her team to review. After one year, their findings showed that “83 percent of participants completed four or more diabetes visits within a year, compared to only 21 percent prior to the study,” and “mean HbA1c decreased from 10.8 to 9.6 among participants who completed the full year.”

In addition, 93 percent of participants were highly satisfied with the program, and more participants were using technology such as insulin pumps and continuous glucose monitors (CGMs). However, one area that did not change significantly was the number of diabetes-related emergency room or hospital visits.

Still, the study shows that telehealth could be a valuable intervention for children and youth with type 1 diabetes to help them better manage their disease and health outcomes. A reduction in HbA1c levels and an increase in frequency of care is encouraging. Telehealth may be one more tool for effectively supporting individuals with T1D.

Research continues to advance the understanding, treatment, and management of T1D. Though not involved with this study, the Diabetes Research Connection (DRC) supports these efforts as well by providing critical funding to early-career scientists studying the disease. Researchers can receive up to $50K for novel, peer-reviewed projects aimed at preventing or curing type 1 diabetes, minimizing its complications, and improving quality of life for individuals living with the disease. Click to learn more about current projects and provide support.

Learn More +